US 12303724
Non-adult human dosing of anti-CD30 antibody-drug conjugates for treatment of hematological or lymphoid cancer
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 12303724 (Non-adult human dosing of anti-CD30 antibody-drug conjugates for treatment of hematological or lymphoid cancer) held by Takeda Pharmaceutical Company Limited expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K2039/55, A61K31/475